Hudson Executive Capital LP

Affiliate at CANTALOUPE, INC.; Director at EAGLE PHARMACEUTICALS, INC.

Sold, on record
$2.6M
Dollars the filings state
Form 4 sales
3
Latest Feb 21, 2023
Form 144 notices
1
Proposed sales
Companies
2
Filed as an executive or holder

Companies

Sales by reason

0
Routine
0
Plan not stated
0
No plan
0
Unusual
Stacked: routine sales under a plan, sales whose filing does not state a plan, sales with no plan, and unusual sales.

Form 4 sales per month, last 12 months.

Sales chart range

Sales by company

Shares sold, every Form 4 sale on record.

Timeline

  1. 1 Form 4 sale EAGLE PHARMACEUTICALS, INC.Plan not stated
    Oct 18, 2019 2019

    Sold 15,544 shares at $62.58 ($973k)

    Hudson Executive Capital LP, Director

    Sold 2% of holdings ($48.6M position)760,324 shares leftFirst sale on recordFiling

  2. 2 Form 4 sale EAGLE PHARMACEUTICALS, INC.Plan not stated
    Oct 25, 2019 +7 days

    Sold 16,931 shares at $63.48 ($1.1M)

    Hudson Executive Capital LP, Director

    Sold 2.3% of holdings ($47.6M position)732,777 shares leftFiling

  3. 3 Form 4 sale CANTALOUPE, INC.No plan
    Feb 21, 2023 +1215 days

    Sold 90,582 shares at $6.30 ($571k)

    Hudson Executive Capital LP, 10% owner

    No 10b5-1 planSold 1% of holdings ($59M position)9.3M shares leftFirst sale on recordFiling

  4. 4 Form 144 notice CANTALOUPE, INC.Notice
    Feb 21, 2024 +365 days

    Filed to sell 89,058 shares ($559k)

    Hudson Executive Capital LP, Affiliate

    No 10b5-1 planFiling

Every transaction

Loading transactions…

Sales and notices (4)

Form 144 notices and Form 4 sales by Hudson Executive Capital LP
Source
Feb 21, 2024Feb 21, 2024CANTALOUPE, INC.AffiliateForm 144 notice89,058$559kNoticeSEC
Feb 21, 2023Feb 21, 2024CANTALOUPE, INC.10% ownerForm 4 sale90,582$571k1.0%No planSEC
Oct 25, 2019Oct 28, 2019EAGLE PHARMACEUTICALS, INC.DirectorForm 4 sale16,931$1.1M2.3%Plan not statedSEC
Oct 18, 2019Oct 18, 2019EAGLE PHARMACEUTICALS, INC.DirectorForm 4 sale15,544$973k2.0%Plan not statedSEC